| Feature | Specification |
|---|---|
| Application | Pre-eclampsia |
| Disorders | Pre-Eclampsia |
The kit is intended for the quantitative determination of soluble Fms-like tyrosine kinase-1 (sFlt-1) in maternal serum using the 6000 DELFIA® Xpress random access immunoanalyzer. The ratio of sFlt-1/PlGF may be used as an aid in diagnosis of pre-eclampsia and for short term prediction of suspected pre-eclampsia together with other biochemical and clinical information.
| Application |
Pre-eclampsia
|
|---|---|
| Brand |
DELFIA® Xpress
|
| Detection Modality |
Time-Resolved Fluorescence (TRF)
|
| Disorders |
Pre-Eclampsia
|
| Instrument Compatibility |
DELFIA Xpress
|
| Regulatory Status |
CE-IVD marked
|
| Sample Type |
Serum
|
| Technology |
DELFIA
|
| Unit Size |
48 assays
|
Are you looking for resources, click on the resource type to explore further.
Brochure for DELFIA prenatal screening solutions and assays including traditional biochemical screening, pre-eclampsia
This brochure is about advanced pre-eclampsia risk assessment using PlGF testing, automated analysis, and integrated prenatal...
We are here to answer your questions.